Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,042,313 papers from all fields of science
Search
Sign In
Create Free Account
Deferoxamine
Known as:
Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-
, DFOM
, Deferoximine
Expand
An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
36 relations
Narrower (13)
4-isothiocyanatobenzyl-desferrioxamine
40SD02
Desferal
N-methylanthranilic-desferrioxamine
Expand
Anuria
Bone Diseases
Chelation Therapy
Corneal Diseases
Expand
Broader (4)
Chelating Agents
Siderophores
feroxamine
hydroxamate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Movement of Atlantic cod, Gadus morhua, tagged in the Gulf of Maine area
J. J. Hunt
,
W. T. Stobo
,
Nova Scotia
,
F. Almeida
1999
Corpus ID: 54982192
Over 22,000 Atlantic cod, Gadus morhua, were tagged with T-bar tags and released in the Gulf of Maine area in 1984-97 and 2400…
Expand
1993
1993
Detection of aluminium(III) binding to citrate in human blood plasma by proton nuclear magnetic resonance spectroscopy.
Jimmy D Bell
,
G. Kubal
,
S. Radulović
,
P. Sadler
,
A. Tucker
In Analysis
1993
Corpus ID: 19994269
Reactions of Al3+ (50-500 mumol l-1) with intact blood plasma and its low relative molecular mass ultrafiltrate (< 5 kDa) have…
Expand
Highly Cited
1986
Highly Cited
1986
Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
H. G. Nebeker
,
D. Andress
,
+5 authors
J. Coburn
Kidney international. Supplement
1986
Corpus ID: 35664042
1986
1986
Clearance of aluminum by hemodialysis: effect of desferrioxamine.
D. Milliner
,
G. Hercz
,
J. H. Miller
,
J. Shinaberger
,
A. Nissenson
,
J. Coburn
Kidney international. Supplement
1986
Corpus ID: 20963730
Highly Cited
1983
Highly Cited
1983
Inhibition of microsomal oxidation of alcohols and of hydroxyl-radical-scavenging agents by the iron-chelating agent desferrioxamine.
A. Cederbaum
,
E. Dicker
Biochemical Journal
1983
Corpus ID: 437568
Rat liver microsomes (microsomal fractions) catalyse the oxidation of straight-chain aliphatic alcohols and of hydroxyl-radical…
Expand
1983
1983
Interactions of pH and ascorbate in intestinal iron absorption.
D. Hungerford
,
M. Linder
Journal of NutriLife
1983
Corpus ID: 4499724
Iron absorption is frequently studied experimentally in animals by placing iron directly into tied-off intestinal segments in…
Expand
1981
1981
Transferrin binding and iron uptake by mouse lymph node cells during transformation in response to concanavalin A.
J. Brock
,
M. Rankin
Immunology
1981
Corpus ID: 32183839
Mouse lymph node cells cultured with Concanavalin A (Con A) in serum-free medium containing 59Fe-transferrin took up 59Fe more…
Expand
Highly Cited
1978
Highly Cited
1978
Lens opacities in thalassemia.
S. Bloomfield
,
A. Markenson
,
D. Miller
,
C. Peterson
Journal of pediatric ophthalmology and strabismus
1978
Corpus ID: 44904648
This is the first case report of cataracts in patients with thalassemia major. Desferrioxamine, an iron-chelating agent is being…
Expand
Review
1976
Review
1976
Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
A. Nienhuis
,
C. Delea
,
R. Aamodt
,
F. Bartter
,
W. Anderson
Birth defects original article series
1976
Corpus ID: 32012572
1975
1975
The effect of combination of chelating agents on the translocation of intramuscularly depostied 239Pu nitrate in the rat.
V. Volf
Health Physics
1975
Corpus ID: 5662957
Abstract The effect of direct injection of chelating agents into simulated puncture wounds contaminated with 239Pu nitrate has…
Expand